COVID-19 |
coronavirus disease 2019 |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
RAS |
renin-angiotensin system |
ERAP |
endoplasmic reticulum aminopeptidase |
ER |
endoplasmic reticulum |
ACE |
angiotensin-converting enzyme |
Ang |
angiotensin |
MERS-CoV |
Middle East respiratory syndrome coronavirus |
AT1R |
Ang type I receptor |
AT2R |
Ang type II receptor |
AT4R |
Ang type IV receptor |
MasR |
Mas receptor |
MHC |
major histocompatibility complex |
WHO |
World Health Organization |
UTR |
untranslated region |
NO |
nitric oxide |
PBMC |
peripheral blood mononuclear cells |
LPS |
lipopolysaccharide |
TNFα |
tumor necrosis factor |
IL |
interleukin |
IFN |
interferon type I |
ROS |
reactive oxygen species |
SNPs |
single nucleotide polymorphisms |
ALDO |
aldosterone |
rhACE2 |
recombinant human ACE2 |
DPP4 |
dipeptidyl peptidase 4 |
LoF |
loss-of-function |